Inactive

The Center for Disease Control and Prevention intends to award a sole source firm fixed price purchace order to Agilent. This is a service agreement for the Agilent nucleic acid belonging to the Labor... The Center for Disease Control and Prevention intends to award a sole source firm fixed price purchace order to Agilent. This is a service agreement for the Agilent nucleic acid belonging to the Laboratory branch,Division of Viral. This service agreement includes all repairs, labor and travel incur duringservice call for all sequencers listed in the contract. This service agreement includes one annual preventive maintenance. The contract assures a three-day on-site response time around for service calls. The agreement also includes field application technical support on-site. Importantly, all hardware and software updates are included for instruments included in the agreement. A determination by the Government not to compete this proposed action will be based on responses to this notice and is solely in the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. All vendors must be registered in the System for Award Management (SAM) at www.sam.gov , prior to an award of a federal contract.This action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit quotations. This is not a request for competitive quotations; however, the Government will review any/all product, capabilities, and pricing information submitted prior to the closure of this notice. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Responsible sources that believe they possess the expertise and capabilities identified above are hereby afforded the opportunity to submit to the Contracting Officer by the due date of this notice, their written capabilities statement and pricing information in the format they choose,not to exceed 10 pages. Please forward, as applicable, any capabilities,product, pricing information (for products, etc.), and/or other pertinent information to Rebecca Rasool,through email at MSO9@cdc.gov. Any responses should be emailed to Rebecca Rasool at MSO9@cdc.gov by July 26, 2024 at 4:00 PM. ET Local. Attachments